Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis
Kathleen Priken Figueroa, Gladys Tapia, Cynthia Cadagan, Nicolás Quezada, Javiera Torres, Amanda D’Espessailles, Paulina Pettinelli
Topics & Concepts
Internal medicineNonalcoholic fatty liver diseaseGlycationEndocrinologySteatosisSteatohepatitisFibrosisNonalcoholic steatohepatitisFatty liverMedicineHepatic fibrosisGastroenterologyReceptorDiseaseLiver Disease Diagnosis and TreatmentAdvanced Glycation End Products researchDiet, Metabolism, and Disease